284 related articles for article (PubMed ID: 15919808)
1. Reduction of hepatic and adipose tissue glucocorticoid receptor expression with antisense oligonucleotides improves hyperglycemia and hyperlipidemia in diabetic rodents without causing systemic glucocorticoid antagonism.
Watts LM; Manchem VP; Leedom TA; Rivard AL; McKay RA; Bao D; Neroladakis T; Monia BP; Bodenmiller DM; Cao JX; Zhang HY; Cox AL; Jacobs SJ; Michael MD; Sloop KW; Bhanot S
Diabetes; 2005 Jun; 54(6):1846-53. PubMed ID: 15919808
[TBL] [Abstract][Full Text] [Related]
2. Antisense oligonucleotides targeted against glucocorticoid receptor reduce hepatic glucose production and ameliorate hyperglycemia in diabetic mice.
Liang Y; Osborne MC; Monia BP; Bhanot S; Watts LM; She P; DeCarlo SO; Chen X; Demarest K
Metabolism; 2005 Jul; 54(7):848-55. PubMed ID: 15988691
[TBL] [Abstract][Full Text] [Related]
3. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice.
Yu XX; Murray SF; Pandey SK; Booten SL; Bao D; Song XZ; Kelly S; Chen S; McKay R; Monia BP; Bhanot S
Hepatology; 2005 Aug; 42(2):362-71. PubMed ID: 16001399
[TBL] [Abstract][Full Text] [Related]
4. Reduced adiposity and improved insulin sensitivity in obese mice with antisense suppression of 4E-BP2 expression.
Yu XX; Pandey SK; Booten SL; Murray SF; Monia BP; Bhanot S
Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E530-9. PubMed ID: 18198353
[TBL] [Abstract][Full Text] [Related]
5. Eburicoic Acid, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic Effects in Palmitate-Treated C2C12 Myotubes and in High-Fat Diet-Fed Mice.
Lin CH; Kuo YH; Shih CC
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099085
[TBL] [Abstract][Full Text] [Related]
6. The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach.
Raichur S; Brunner B; Bielohuby M; Hansen G; Pfenninger A; Wang B; Bruning JC; Larsen PJ; Tennagels N
Mol Metab; 2019 Mar; 21():36-50. PubMed ID: 30655217
[TBL] [Abstract][Full Text] [Related]
7. Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents.
Vatner DF; Goedeke L; Camporez JG; Lyu K; Nasiri AR; Zhang D; Bhanot S; Murray SF; Still CD; Gerhard GS; Shulman GI; Samuel VT
Diabetologia; 2018 Jun; 61(6):1435-1446. PubMed ID: 29497783
[TBL] [Abstract][Full Text] [Related]
8. Reduction of hepatosteatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide.
Imai Y; Varela GM; Jackson MB; Graham MJ; Crooke RM; Ahima RS
Gastroenterology; 2007 May; 132(5):1947-54. PubMed ID: 17484887
[TBL] [Abstract][Full Text] [Related]
9. High-fat diet and glucocorticoid treatment cause hyperglycemia associated with adiponectin receptor alterations.
de Oliveira C; de Mattos AB; Biz C; Oyama LM; Ribeiro EB; do Nascimento CM
Lipids Health Dis; 2011 Jan; 10():11. PubMed ID: 21244702
[TBL] [Abstract][Full Text] [Related]
10. Transthyretin Antisense Oligonucleotides Lower Circulating RBP4 Levels and Improve Insulin Sensitivity in Obese Mice.
Zemany L; Bhanot S; Peroni OD; Murray SF; Moraes-Vieira PM; Castoldi A; Manchem P; Guo S; Monia BP; Kahn BB
Diabetes; 2015 May; 64(5):1603-14. PubMed ID: 25524914
[TBL] [Abstract][Full Text] [Related]
11. Hepatic Glucocorticoid Receptor Plays a Greater Role Than Adipose GR in Metabolic Syndrome Despite Renal Compensation.
Bose SK; Hutson I; Harris CA
Endocrinology; 2016 Dec; 157(12):4943-4960. PubMed ID: 27754788
[TBL] [Abstract][Full Text] [Related]
12. Antidiabetic and Antihyperlipidemic Properties of a Triterpenoid Compound, Dehydroeburicoic Acid, from Antrodia camphorata in Vitro and in Streptozotocin-Induced Mice.
Kuo YH; Lin CH; Shih CC
J Agric Food Chem; 2015 Nov; 63(46):10140-51. PubMed ID: 26503742
[TBL] [Abstract][Full Text] [Related]
13. SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats.
Erion DM; Yonemitsu S; Nie Y; Nagai Y; Gillum MP; Hsiao JJ; Iwasaki T; Stark R; Weismann D; Yu XX; Murray SF; Bhanot S; Monia BP; Horvath TL; Gao Q; Samuel VT; Shulman GI
Proc Natl Acad Sci U S A; 2009 Jul; 106(27):11288-93. PubMed ID: 19549853
[TBL] [Abstract][Full Text] [Related]
14. Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism.
Koliwad SK; Kuo T; Shipp LE; Gray NE; Backhed F; So AY; Farese RV; Wang JC
J Biol Chem; 2009 Sep; 284(38):25593-601. PubMed ID: 19628874
[TBL] [Abstract][Full Text] [Related]
15. Adipose Tissue Tumor Necrosis Factor-α. and Interleukin-6 Response to Glucocorticoid Treatment during Inflammation.
Zubel-Lojek J; Oclon E; Latacz A; Pierzchala-Koziec K
Folia Biol (Krakow); 2016; 64(3):205-212. PubMed ID: 29847081
[TBL] [Abstract][Full Text] [Related]
16. Mechanism for blockade of angiotensin subtype 1 receptors to lower plasma glucose in streptozotocin-induced diabetic rats.
Chan P; Liu IM; Tzeng TF; Yang TL; Cheng JT
Diabetes Obes Metab; 2007 Jan; 9(1):39-49. PubMed ID: 17199717
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of the glucocorticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus.
Opherk C; Tronche F; Kellendonk C; Kohlmüller D; Schulze A; Schmid W; Schütz G
Mol Endocrinol; 2004 Jun; 18(6):1346-53. PubMed ID: 15031319
[TBL] [Abstract][Full Text] [Related]
18. Swertisin rich fraction from Enicostema littorale ameliorates hyperglycemia and hyperlipidemia in high-fat fed diet and low dose streptozotacin induced type 2 diabetes mellitus in rats.
Mokashi P; Bhatt LK; Khanna A; Pandita N
Biomed Pharmacother; 2017 Dec; 96():1427-1437. PubMed ID: 29031588
[TBL] [Abstract][Full Text] [Related]
19. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
[TBL] [Abstract][Full Text] [Related]
20. Effects of Bofu-Tsusho-San on diabetes and hyperlipidemia associated with AMP-activated protein kinase and glucose transporter 4 in high-fat-fed mice.
Lin CH; Kuo YH; Shih CC
Int J Mol Sci; 2014 Nov; 15(11):20022-44. PubMed ID: 25375187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
